Improvement of embryonic dopaminergic neurone survival in culture and after grafting into the striatum of hemiparkinsonian rats by CEP-1347

Journal of Neurochemistry

Volumn 88, Issue 3, 2004, Pages 698-707

  Boll, Jette Bisgaard ^a   Geist, Marie Aavang ^a   Kaminski Schierle, Gabriele S ^b   Petersen, Karina ^a   Leist, Marcel ^a   Vaudano, Elisabetta ^a  

^a H LUNDBECK A S   (Denmark)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

CEP 1347; Dopaminergic; Mixed lineage kinase; Neuroprotection; Substantia nigra; Transplantation

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CEP 11004; CEP 1347; ENZYME INHIBITOR; MIXED LINEAGE KINASE INHIBITOR; NEUROPROTECTIVE AGENT; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CELL SUSPENSION; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; EMBRYO CELL; MESENCEPHALON; NERVE CELL; NERVE GRAFT; NONHUMAN; OUTCOMES RESEARCH; PARKINSONISM; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; STRESS; SUBSTANTIA NIGRA; SURVIVAL TIME; TISSUE SPECIFICITY; TISSUE TRANSPLANTATION;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CARBAZOLES; CELL SURVIVAL; CELLS, CULTURED; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETAL TISSUE TRANSPLANTATION; INDOLES; NEURONS; PARKINSONIAN DISORDERS; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0742306509     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02198.x     Document Type: Article

References (49)

1. Barker R. A., Dunnett S. B., Faissner A. and Fawcett J. W. (1996) The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp. Neurol. 141, 79-93.
2. Barthwal M. K., Sathynarayana P., Kundu C. N., Rana B., Pradeep A., Sharma C., Woodgett J. and Rana A. (2003) Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival. J. Biol. Chem. 278, 3897-3902.
3. Bozyczko-Coyne D., O-Kane T. M., Wu Z. L., Dobrzanski P., Murthy S., Vaught J. L. and Scott R. W. (2001) CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Abeta-induced cortical neuron apoptosis. J. Neurochem. 77, 849-863.
4. Branton R. L. and Clarke D. J. (1999) Apoptosis in primary cultures of E 14 rat ventral mesencephala: time course of dopaminergic cell death and implications for neural transplantation. Exp. Neurol. 160, 88-98.
5. Brundin P., Isacson O. and Bjorklund A. (1985) Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331, 251-259.
6. Brundin P., Karlsson J., Emgard M., Schierle G. S., Hansson O., Petersen A. and Castilho R. F. (2000a) Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. 9, 179-195.
7. Brundin P., Pogarell O., Hagell P. et al. (2000b) Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123, 1380-1390.
8. Choi W. S., Yoon S. Y., Oh T. H., Choi E. J., O'Malley K. L. and Oh Y. J. (1999) Two distinct mechanisms are involved in 6-hydroxydopamine-and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J. Neurosci. Res. 57, 86-94,
9. Chun H. S., Gibson G. E., DeGiorgio L. A., Zhang H., Kidd V. J. and Son J. H. (2001) Dopaminergic cell death induced by MPP (+), oxidant and specific neurotoxicants shares the common molecular mechanism. J. Neurochem. 76, 1010-1021.
10. Cicchetti F., Costantini L., Belizaire R., Burton W., Isacson O. and Fodor W. (2002) Combined inhibition of apoptosis and complement improves neural graft survival of embryonic rat and porcine mesencephalon in the rat brain. Exp. Neurol. 177, 376-384.
11. Emgard M., Karlsson J., Hansson O. and Brundin P. (1999) Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts. Exp. Neurol. 160, 279-288.
12. Engele J. (1998) Spatial and temporal growth factor influences on developing midbrain dopaminergic neurons. J. Neurosci. 53, 405-414.
13. Fawcett J. W., Barker R. A. and Dunnett S. B. (1995) Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon. Exp. Brain Res. 106, 275-282.
14. Freed C. R., Greene P. E., Breeze R. E. et al. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344, 710-719.
15. Gearan T., Castillo O. A. and Schwarzschild M. A. (2001) The parkinsonian neurotoxin, MPP+ induces phosphorylated c-Jun in dopaminergric neurons of mesencephalic cultures. Parkinsonism Relat. Disord. 8, 19-22.
16. Grasbon-Frodl E. M., Nakao N. and Brundin P. (1996) The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4 degrees C and subsequently used for cultures or intracerebral transplantation. Brain Res. Bull. 39, 341-347.
17. Greene L. A. and Tischler A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl Acad. Sci. USA 73, 2424-2428.
18. Gregersen R., Lambertsen K. and Finsen B. (2000) Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 20, 53-65.
19. Hagell P. and Brundin P. (2001) Cell survival and clinical outcome following intrastriatal transplantation in Parkinson's disease. J. Neuropathol. Exp. Neurol. 60, 741-752.
20. Hall E. D. (1997) Lipid antioxidant neuroprotectants for acute and chronic neurodegenerative disorders, in Neuroprotection in CNS Diseases (Bär, P. R., Beal, M. F., eds), pp. 161-181. Marcel Dekker, New York.
21. Hansson O., Castilho R. F., Kaminski Schierle G. S., Karlsson J., Nicotera P., Leist M. and Brundin P. (2000) Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons. Exp. Neurol. 164, 102-111.
22. Harper S. J. and LoGrasso P. (2001) Signalling for survival and death in neurons: the role of stress-activated kinases, JNK and p38. Cell Signal. 13, 299-310.
23. Harris C., Maroney A. C. and Johnson E. M. Jr (2002a) Identification of JNK-dependent and -independent components of cerebellar granule neuron apoptosis. J. Neurochem. 83, 992-1001.
24. Harris C. A., Deshmukh M., Tsui-Pierchala B., Maroney A. C. and Johnson E. M. (2002b) Inhibition of the c-Jun N-terminal kinase signaling pathway by the mixed lineage kinase inhibitor CEP-1347 (KT7515) preserves metabolism and growth of trophic factor-deprived neurons. J. Neurosci. 22, 103-113.
25. Ip Y. T. and Davis R. J. (1998) Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr Opin. Cell Biol. 10, 205-219.
26. Kaminski Schierle G. S., Hansson O. and Brundin P. (1999a) Flunarizine improves the survival of grafted dopaminergic neurons. Neurosci. 94, 17-20.
27. Kaminski Schierle G. S., Hansson O., Ferrando-May E., Nicotera P., Brundin P. and Leist M. (1999b) Neuronal death in nigral grafts in the absence of poly (ADP-ribose) polymerase activation. Neuroreport 10, 3347-3351.
28. Karlsson J., Emgard M., Gido G., Wieloch T. and Brundin P. (2000) Increased survival of embryonic nigral neurons when grafted to hypothermic rats. Neuroreport 11, 1665-1668.
29. Karlsson J., Emgard M. and Brundin P. (2002) Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants. Brain Res. 955, 268-280.
30. Kordower J. H., Freeman T. B., Chen E. Y., Mufson E. J., Sanberg P. R., Hauser R. A., Snow B. and Olanow C. W. (1998) Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord. 13, 383-393.
31. Lindvall O. and Hagell P. (2000) Clinical observations after neural transplantation in Parkinson's disease. Prog. Brain Res. 127, 299-320.
32. Maroney A. C., Glicksman M. A., Basma A. N. et al. (1998) Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J. Neurosci. 18, 104-111.
33. Maroney A. C., Finn J. P., Connors T. J. et al. (2001) Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. J. Biol. Chem. 276, 25302-25308.
34. Mielke K. and Herdegen T. (2002) Fatal shift of signal transduction is an integral part of neuronal differentiation: JNKs realize TNFα-mediated apoptosis in Neuronlike, but not naive PC12 cells. Mol. Cell. Neurosci. 20, 211-224.
35. Møller A., Christophersen P., Drejer J., Axelsson O., Peters D., Jensen L. H. and Nielsen E. Ø. (1995) Pharmacological profile and anti-ischemic properties of the Ca2+-channel blocker NS-638 Neurol. Res. 17, 353-360.
36. Murakata C., Kaneko M., Gessner G. et al. (2002) Mixed lineage kinase activity of indolocarbazole analogues. Bioorg. Med. Chem. Lett. 12, 147-150.
37. Nakao N., Frodl E. M., Duan W. M., Widner H. and Brundin P. (1994) Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl Acad. Sci. USA 91, 12408-12412.
38. Piccini P., Brooks D. J., Bjorklund A. et al. (1999) Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat. Neurosci. 2, 1137-1140.
39. Salehi A. H., Xanthoudakis S. and Barker P. A. (2002) NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway. J. Biol. Chem. 277, 48043-48050.
40. Saporito M. S., Brown E. M., Miller M. S. and Carswell S. (1999) CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo. J Pharmacol. Exp. Ther. 288, 421-427.
41. Saporito M. S., Thomas B. A. and Scott R. W. (2000) MPTP activates c-Jun NH (2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J. Neurochem. 75, 1200-1208.
42. Schierle G. S., Hansson O., Leist M., Nicotera P., Widner H. and Brundin P. (1999) Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med. 5, 97-100.
43. Schmidt R. H., Bjorklund A., Stenevi U., Dunnett S. B. and Gage F. H. (1983) Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiol. Scand. Suppl. 522, 19-28.
44. Sinclair S. R., Fawcett J. W. and Dunnett S. B. (1999) Dopamine cells in nigral grafts differentiate prior to implantation. Eur. J. Neurosci. 11, 4341-4348.
45. Sortwell C. E., Pitzer M. R. and Collier T. J. (2000) Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival. Exp. Neurol. 165, 268-277.
46. Tabbal S., Fahn S. and Frucht S. (1998) Fetal tissue transplantation in Parkinson's disease. Curr. Opin. Neurol. 11, 341-349.
47. Ungerstedt U. and Arbuthnott G. W. (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-493.
48. Xu Z., Maroney A. C., Dobrzanski P., Kukekov N. V. and Greene L. A. (2001) The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. Mol. Cell Biol. 21, 4713-4724.
49. Zawada W. M., Zastrow D. J., Clarkson E. D., Adams F. S., Bell K. P. and Freed C. R. (1998) Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786, 96-103.